Look At Analyst Expectations For A Better Read On Cameco Corp. (NYSE: CCJ)

Currently, there are 434.18M common shares owned by the public and among those 433.02M shares have been available to trade.

The company’s stock has a 5-day price change of 8.24% and 8.97% over the past three months. CCJ shares are trading 8.47% year to date (YTD), with the 12-month market performance up to 80.64% higher. It has a 12-month low price of $24.64 and touched a high of $51.33 over the same period. CCJ has an average intraday trading volume of 5.21 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.92%, 7.27%, and 17.75% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Institutional ownership of Cameco Corp. (NYSE: CCJ) shares accounts for 75.54% of the company’s 434.18M shares outstanding.

It has a market capitalization of $20.30B and a beta (3y monthly) value of 0.91. The stock’s trailing 12-month PE ratio is 76.00, while the earnings-per-share (ttm) stands at $0.62. The company has a PEG of 1.57 and a Quick Ratio of 0.97 with the debt-to-equity ratio at 0.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.95% over the week and 4.13% over the month.

Analysts forecast that Cameco Corp. (CCJ) will achieve an EPS of $0.26 for the current quarter, $0.24 for the next quarter and $1.28 for 2025. The lowest estimate earnings-per-share for the quarter is $0.16 while analysts give the company a high EPS estimate of $0.52. Comparatively, EPS for the current quarter was $0.2 a year ago. Earnings per share for the fiscal year are expected to increase by 87.43%, and 56.26% over the next financial year. EPS should grow at an annualized rate of 48.31% over the next five years, compared to 13.73% over the past 5-year period.

Looking at the support for the CCJ, a number of firms have released research notes about the stock. Goldman stated their Buy rating for the stock in a research note on Apr-02-24, with the firm’s price target at $55. Cantor Fitzgerald on their part issued Buy rating on October 25, 2023.

Most Popular

Related Posts